Status:
ENROLLING_BY_INVITATION
FAP-targeting PET/CT for Noninvasive Monitoring of Renal Fibrosis
Lead Sponsor:
Peking University First Hospital
Conditions:
CKD
Renal Fibrosis
Eligibility:
All Genders
18+ years
Phase:
NA
Brief Summary
Chronic kidney disease (CKD) is an irreversible change of kidney function and structure caused by many reasons. The main threat of CKD to human health is progressive renal function decline. Delaying t...
Eligibility Criteria
Inclusion
- Patients with chronic kidney disease
- Renal pathology was performed within 2 weeks
Exclusion
- Pregnant or lactating patients
Key Trial Info
Start Date :
April 10 2024
Trial Type :
INTERVENTIONAL
Allocation :
ESTIMATED
End Date :
May 10 2027
Estimated Enrollment :
90 Patients enrolled
Trial Details
Trial ID
NCT06563765
Start Date
April 10 2024
End Date
May 10 2027
Last Update
August 7 2025
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Peking University First Hospital
Beijing, Beijing Municipality, China